- Conditions
- Aneurysmal Subarachnoid Hemorrhage, Vasospasm, Cerebral, Transcutaneous Vagal Nerve Stimulation (tVNS), Endovascular Treatment
- Interventions
- Transcutaneous Vagal Nerve Stimulation
- Device
- Lead sponsor
- Marshall Holland
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
Source: ClinicalTrials.gov public record
Updated Aug 19, 2025 · Synced May 22, 2026, 5:47 AM EDT